Metastudie;Doi;Titel;Publikationsjahr;Anzahl Studien;Studienname;Publikationsjahr;Geschlecht;Index_Geschlecht;AlterText;Alter;Alter.gewichte;Alterrange;;;;;;;;;;;
121;https://doi.org/10.1002/14651858.CD001922.pub3;Physical methods for preventing deep vein thrombosis in stroke;2010;4;CLOTS ;2009;Sex: males 49.4% (620/1256) in the treatment group and 49.3% in the control group (622/1262);both;"Country: UK, Italy and Australia
Total number of participants: 2518
Total available for analysis: 2518
Age: 76 years (68 to 83) for both groups
Sex: males 49.4% (620/1256) in the treatment group and 49.3% in the control group (622/1262)
Immobilisation: yes
Inclusion criteria: patients admitted with an acute stroke up to day 3 post?admission
Exclusion criteria: peripheral vascular disease, or with diabetic/sensory neuropathy, if clinicians judged GCS could cause skin damage
Full intention?to?treat analysis: performed ";76;;68 - 83;;;Gesamt 601;;;;;;;;
121;https://doi.org/10.1002/14651858.CD001922.pub3;Physical methods for preventing deep vein thrombosis in stroke;2010;4;Lacut ;2005;Sex: males 62% (46/74) in the treatment group and 55% (42/77) in the control group;both;"Country: France
Total number of participants: 151
Total available for analysis: 133
Age: mean 59.9 (ñ14.7) years in the treatment group and 65.7 (ñ12.7) years in the control group; P < 0.01
Sex: males 62% (46/74) in the treatment group and 55% (42/77) in the control group
Immobilisation: no
Inclusion criteria: age over 18 years, traumatic or spontaneous ICH with or without SAH
Exclusion criteria: extra or subdural haematomas, traumatic ICH due to polytrauma including the lower limbs, haemorrhagic transformation of ischaemic infarct and vasculitis, DVT within the previous 3 months, lower?limb arteriopathy, venous graft, wound in the lower limb related either to a vascular disease or a trauma, 'do not resuscitate' order, and  > 24?hour delay since hospital admission
Full intention?to?treat analysis: not performed ";62,8;62,858;;;;exclusion:;Begrndung;;;;;;;
121;https://doi.org/10.1002/14651858.CD001922.pub3;Physical methods for preventing deep vein thrombosis in stroke;2010;4;Muir ;2000;Sex: not specified;not reported;"Country: UK
Total number of participants: 98 (1 missing data)
Total available for analysis: 71
Age: mean age > 73 years
Sex: not specified
Immobilisation: yes
Inclusion criteria: acute stroke within 24 hours
Exclusion criteria: patients with coma, life?threatening intercurrent illness, critical lower limb ischaemia or severe dermatological conditions
Full intention?to?treat analysis was not performed ";> 73;;;;371;https://doi.org/10.1002/14651858.CD009586.pub3;"Screening people over 65 years of age for atrial fibrillation increases the rate of detection; Not everyone with atrial fibrillation experiences symptoms";;;;;;;
121;https://doi.org/10.1002/14651858.CD001922.pub3;Physical methods for preventing deep vein thrombosis in stroke;2010;4;Prasad ;1982;Sex: males 53.8% in the treatment group (8/13) and 38.5% (5/13) in the control group;both;"Country: UK
Total number of participants: 26
Total available for analysis: 26
Age: mean age 78 years in the treatment group and 80 years in the control group
Sex: males 53.8% in the treatment group (8/13) and 38.5% (5/13) in the control group
Immobilisation:  yes
Inclusion criteria: all patients admitted for acute stroke within 72 hours
Exclusion criteria: patients in coma or not specified other clinically unacceptable conditions
Full intention?to?treat analysis was not possible ";79;79;;;271;https://doi.org/10.1002/14651858.CD013267.pub2;Randomised controlled trials (RCTs) comparing ET plus CMT with CMT alone for the treatment of symptomatic ICAS. ET modalities included angioplasty alone, balloon?mounted stent, and angioplasty followed by placement of a self?expanding stent. CMT included antiplatelet therapy in addition to control of risk factors such as hypertension, hyperlipidaemia, and diabetes.;;;;;;;
80;https://doi.org/10.1002/14651858.CD005952.pub2;Therapy?based rehabilitation services for patients living at home more than one year after stroke;2008;5;Green ;2002;58% male;both;"UK (Bradford)
170 participants (85 intervention and 85 control)
Mean age 71.5 years, 58% male
Barthel score at baseline: intervention group mean 18 (IQR 16 to 19); control group mean 18 (IQR 16 to 19)
Clinical definition of stroke
Participants recruited from hospital and community stroke register
Inclusion criteria: older than 50 years, had a stroke a year or more and had associated mobility problems. Mobility problem was defined as: use of a mobility aid, fall in the previous three months, unable to manage stairs/slopes/uneven surfaces independently and slow gait speed ";71,5;;;;173;https://doi.org/10.1002/14651858.CD008277.pub2;Blood pressure targets for hypertension in people with diabetes mellitus;;;;;;;
80;https://doi.org/10.1002/14651858.CD005952.pub2;Therapy?based rehabilitation services for patients living at home more than one year after stroke;2008;5;Mulder ;1989;53% male;both;"Netherlands (Maastrict)
56 participants (38 intervention and 18 control). Analyses were based only at the first follow?up assessment points (at 13 to 28 weeks)
Mean age 55.1 years, 53% male
Participants recruited from a rehabilitation centre in the Netherlands
Inclusion criteria: two?tier selection. First tier: participant < 70 years old, living within 30 km, not having serious progressive disease and not having resumed work. Second tier: expected ability to function in a group as assessed by the rehabilitation team ";55,1;;< 70;;309;https://doi.org/10.1002/14651858.CD012675.pub3;To establish the effectiveness of interventions delivered by mobile phone to improve adherence to medication prescribed for the primary prevention of CVD in adults.;;;;;;;
80;https://doi.org/10.1002/14651858.CD005952.pub2;Therapy?based rehabilitation services for patients living at home more than one year after stroke;2008;5;Sackley ;2006;;not reported;"UK (Oxfordshire)
118 participants (63 residents from 6 homes in intervention group and 55 residents from 6 homes in control group)
Mean age 88.6 years
Participants recruited from 12 nursing and residential homes
Barthel Score at baseline: intervention mean 10.1 (SD 5.7); control mean 9.5 (SD 5.2)
Inclusion criteria: resident in nursing and residential homes, had moderate to severe stroke?related disability (Barthel Index score 4 to 15 inclusive) ";88,6;;;;196;https://doi.org/10.1002/14651858.CD004170.pub3;participants had acquired brain injury (ABI) from any cause (including traumatic brain injury (TBI);;;;;;;
80;https://doi.org/10.1002/14651858.CD005952.pub2;Therapy?based rehabilitation services for patients living at home more than one year after stroke;2008;5;Wade ;1992;50% male;both;"UK (Oxfordshire)
94 participants (49 intervention and 45 control)
Mean age 72.3 years; 50% male
Barthel Index score at baseline: control mean 16.2 (SD 3.1), intervention mean 17.0 (SD 2.8)
Clinician definition of stroke
Patients recruited from Oxfordshire Stroke Project, Rivermead Rehabilitation Centre, local practitioners and radio broadcasting
Inclusion criteria: mobility problems more than 1 year after stroke, used walking or mobility aid, fall in previous 3 months, unable to manage stairs/slopes/uneven surfaces independently and had slow gait speed ";72,3;;;;233;https://doi.org/10.1002/14651858.CD008068.pub2;Almitrine?Raubasine combination for dementia;;;;;;;
80;https://doi.org/10.1002/14651858.CD005952.pub2;Therapy?based rehabilitation services for patients living at home more than one year after stroke;2008;5;Werner ;1996;50% male;both;"US (Ann Arbor)
49 participants (28 intervention and 16 controls, with later addition of 5 controls)
Mean age 59 +/? 9 years with 50% male
Clinical (or radiological) definition of stroke
Participants recruited from 3 local outpatient rehabilitation programs in Michigan
Inclusion criteria: between 6 months and 5 years post stroke, functional communication profile score > 60%, no clinical sign of medical co?morbidities, no generalised sensory deficit, no history of recurrent stroke, no therapeutic intervention in the last 4 months and evidence of functional limitation <7 on Functional Independence Measure ";59;;;;576;https://doi.org/10.1002/14651858.CD010680.pub2;Ankle brachial index for the diagnosis of lower limb peripheral arterial disease;;;;;;;
190;https://doi.org/10.1002/14651858.CD000398.pub2;Nitric oxide donors (nitrates), L?arginine, or nitric oxide synthase inhibitors for acute stroke;2017;5;Ankolekar ;2013;"Male: treatment 15 (65%); control 7 (43.8%)";both;"UK, single centre
41 participants: treatment 25; control 16
Mean age: treatment 79 years; control 81 years
Male: treatment 15 (65%); control 7 (43.8%)
Inclusion: FAST positive test; systolic BP ? 140 mmHg; age > 40 years for men and > 55 years for women
Time to randomisation: within 4 hours of onset";80;79,78;;;489;https://doi.org/10.1002/14651858.CD012548.pub2;Degarelix for treating advanced hormone?sensitive prostate cancer;;;;;;;
190;https://doi.org/10.1002/14651858.CD000398.pub2;Nitric oxide donors (nitrates), L?arginine, or nitric oxide synthase inhibitors for acute stroke;2017;5;Bath ;2001;"Male: treatment 6 (38%); control; 12 (57%)";both;"UK, single centre
37 participants: treatment 16; control 21
Age: treatment 76 years; control 72 years
Male: treatment 6 (38%); control; 12 (57%)
Inclusion: IS or ICH
Time to randomisation: within five days of onset";74;73,73;;;428;https://doi.org/10.1002/14651858.CD008613.pub2;Hormone replacement therapy for women with type 1 diabetes mellitus;;;;;;;
190;https://doi.org/10.1002/14651858.CD000398.pub2;Nitric oxide donors (nitrates), L?arginine, or nitric oxide synthase inhibitors for acute stroke;2017;5;ENOS ;2015;"Male: treatment 1147 (57%); control 1150 (57%)";both;"International (23 countries), multicentre (173 sites)
4011 participants: treatment 2000; control 2011
Age: treatment 70 years; control 70 years
Male: treatment 1147 (57%); control 1150 (57%)
Inclusion: IS or ICH; motor deficit in arm or leg, or both; systolic BP 140 to 220 mmHg
Time to randomisation: within 48 hours of onset";70;70;;;397;https://doi.org/10.1002/14651858.CD010222.pub4;Anticoagulant treatment for subsegmental pulmonary embolism;;;;;;;
190;https://doi.org/10.1002/14651858.CD000398.pub2;Nitric oxide donors (nitrates), L?arginine, or nitric oxide synthase inhibitors for acute stroke;2017;5;Rashid ;2002;"Male: treatment 28 (46.7%); control 13 (43.3%)";both;"UK, single centre
90 participants: treatment 60; control 30
Mean age: treatment 70.8 years; control 73.9 years
Male: treatment 28 (46.7%); control 13 (43.3%)
Inclusion: IS or ICH
Time to randomisation: within 72 hours of onset";72,35;71,83;;;200;https://doi.org/10.1002/14651858.CD008980.pub3;Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation;;;;;;;
190;https://doi.org/10.1002/14651858.CD000398.pub2;Nitric oxide donors (nitrates), L?arginine, or nitric oxide synthase inhibitors for acute stroke;2017;5;Willmot ;2006;"Male: treatment 2 (16.7%); control 3 (50%)";both;"UK, single centre
18 participants: treatment 12; control 6
Age: treatment 69 years; control 70 years
Male: treatment 2 (16.7%); control 3 (50%)
Inclusion: IS or ICH; previously independent; clinical stroke syndrome and limb weakness
Time to randomisation: within 5 days of onset";69,5;69,571;;;313;https://doi.org/10.1002/14651858.CD003333.pub3;Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm;;;;;;;
180;https://doi.org/10.1002/14651858.CD012575.pub2;Implementation interventions to promote the uptake of evidence?based practices in stroke rehabilitation;2020;9;Abdul Aziz;2014;Sex and ethnicity: not described;not reported;"Healthcare professionals: 10 public health centres each with primary care teams comprising doctors, nurses, physiotherapists and occupational therapists. Demographics of staff within clusters not provided

Patients: stroke survivors (n = 151)

Intervention group: n = 86

Control group: n = 65

Mean age of stroke survivors 60.2 (SD 9.5) years, median duration poststroke 2.25 (IQR 5.1) years

Sex and ethnicity: not described

Setting: community public health centres

Country: Malaysia ";60,2;;;;497;https://doi.org/10.1002/14651858.CD003489.pub2;stroke etiology: 13 ischemic, 2 hemorrhagic;;;;;;;
180;https://doi.org/10.1002/14651858.CD012575.pub2;Implementation interventions to promote the uptake of evidence?based practices in stroke rehabilitation;2020;9;Forster ;2013;"Experimental group: n = 450, 57% men, mean age 71.0 (SD 12.76)

Control group: n = 478, 55% men, mean age 71.3 (SD 12.18)";both;"Healthcare professionals: 36 stroke rehabilitation units. Staff involved in study included physiotherapists, occupational therapists, speech and language therapists, nurses, dieticians, stroke co?ordinators and stroke consultants. Number of staff involved in initial training was 56. Demographics of staff within clusters not provided.

Patients: stroke survivors (n = 928)

Experimental group: n = 450, 57% men, mean age 71.0 (SD 12.76)

Control group: n = 478, 55% men, mean age 71.3 (SD 12.18)

Ethnicity:

Intervention group: white 95.3%

Control group: white 92.9%

Setting: inpatient stroke rehabilitation units

Country: UK ";71,15;71,155;;;439;https://doi.org/10.1002/14651858.CD005313;Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction;;;;;;;
180;https://doi.org/10.1002/14651858.CD012575.pub2;Implementation interventions to promote the uptake of evidence?based practices in stroke rehabilitation;2020;9;Forster ;2015;"Experimental group: n = 108, 32.5% men, mean age 61.0 (SD 15.02) years

Control group: n = 100, 32% men, mean age 61.4 (SD 14.07) years";both;"Healthcare professionals: 29 clusters of stroke care co?ordinators or stroke care co?ordinator services. Number and demographics of staff within clusters not provided.

15 intervention clusters, 14 control clusters

Patients: stroke survivors (n = 800)

Experimental group: n = 401, 53.6% men, mean age 70.9 (SD 13.18) years

Control group: n = 399, 54.6% men, mean age 72.5 (SD 12.84) years

Ethnicity:

Intervention group: white 96.8%

Control group: white 97.5%

Carers: n = 208

Experimental group: n = 108, 32.5% men, mean age 61.0 (SD 15.02) years

Control group: n = 100, 32% men, mean age 61.4 (SD 14.07) years

Setting: community?based setting: outpatients and home?based care

Country: UK ";61,2;61,192;;;272;https://doi.org/10.1002/14651858.CD012502.pub2;Ezetimibe for the prevention of cardiovascular disease and all?cause mortality events;;;;;;;
180;https://doi.org/10.1002/14651858.CD012575.pub2;Implementation interventions to promote the uptake of evidence?based practices in stroke rehabilitation;2020;9;McCluskey ;2016;"Experimental group: n = 164, 55% men, mean age 67 (SD 16) years

Control group: n = 115, 56% men, mean age 67 (SD 14) years";both;"Healthcare professionals: 22 community teams comprised of occupational therapists and physiotherapists. Number and demographics of therapists within clusters not provided.

Patients: stroke survivors (n = 542)

Preintervention

Experimental group: n = 164, 55% men, mean age 67 (SD 16) years

Control group: n = 115, 56% men, mean age 67 (SD 14) years

Postintervention

Experimental group: n = 164, 62% men, mean age 68 (SD 14) years

Control group: n = 115, 59% men, mean age 67 (SD 15) years

Ethnicity: not described

Setting: community rehabilitation centres providing outpatient, day therapy or home?based rehabilitation

Country: Australia ";67,5;67,588;;;82;https://doi.org/10.1002/14651858.CD005950.pub5;stroke etiology: 13 ischemic, 2 hemorrhagic;;;;;;;
180;https://doi.org/10.1002/14651858.CD012575.pub2;Implementation interventions to promote the uptake of evidence?based practices in stroke rehabilitation;2020;9;Pennington ;2005;Patient demographic information (e.g. sex/age/ethnicity) not provided;not reported;"Healthcare professionals: 17 speech and language therapy departments comprising speech and language therapists. Number and demographics of therapists within clusters not provided.

Patients: stroke survivors (n = 1470)

Intervention A: n = 708

Intervention B: n = 762

Patient demographic information (e.g. sex/age/ethnicity) not provided

Setting: hospitals providing inpatient services to adults and children

Country: England ";not reported;;;;490;https://doi.org/10.1002/14651858.CD010079.pub3;Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations;;;;;;;
180;https://doi.org/10.1002/14651858.CD012575.pub2;Implementation interventions to promote the uptake of evidence?based practices in stroke rehabilitation;2020;9;Power ;2014;"Experimental group: n = 3533, 48.2% men, mean age not available

Control group: n = 3059, 47.3% men, mean age not available";both;"Healthcare professionals: 21 hospital trusts with multidisciplinary teams comprising radiographers, stroke co?ordinators, specialist stroke nurses, occupational therapists, physiotherapists and healthcare assistants. Number, disciplines and demographics of therapists within clusters not provided.

Patients: stroke survivors (n = 6592)

Experimental group: n = 3533, 48.2% men, mean age not available

Control group: n = 3059, 47.3% men, mean age not available

Ethnicity: not described

Setting: inpatient wards in hospitals

Country: UK ";not reported;;;;291;https://doi.org/10.1002/14651858.CD003085.pub3;Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage;;;;;;;
180;https://doi.org/10.1002/14651858.CD012575.pub2;Implementation interventions to promote the uptake of evidence?based practices in stroke rehabilitation;2020;9;Salbach ;2017;"Facilitated intervention group preintervention: median 62 (IQR 57?77) years, 69% men

Facilitated intervention group postintervention: median 68 (IQR 60?78) years, 65% men

Passive intervention group preintervention: median 71 (IQR 62?79) years, 52% men

Passive intervention postintervention: median 72 (IQR 65?79) years, 57% men



Facilitated intervention group preintervention: median 64 (IQR 57?77) years, 68% men

Facilitated intervention group postintervention: median 68 (IQR 60?78) years, 65% men

Passive intervention preintervention: median 73 (IQR 62?79) years, 54% men

Passive intervention postintervention: median 72 (IQR 64?79) years, 55% men";both;"Healthcare professionals: 20 rehabilitation units comprising nurses, occupational therapists and physiotherapists. Number and demographics of staff within clusters not provided.

Patients: stroke survivors (n = 312)

Intervention group: n = 169

Control group: n = 143

For 7 treatments implemented by nurses and therapists:

Facilitated intervention group preintervention: median 62 (IQR 57?77) years, 69% men

Facilitated intervention group postintervention: median 68 (IQR 60?78) years, 65% men

Passive intervention group preintervention: median 71 (IQR 62?79) years, 52% men

Passive intervention postintervention: median 72 (IQR 65?79) years, 57% men

For 11 treatments implemented by therapists:

Facilitated intervention group preintervention: median 64 (IQR 57?77) years, 68% men

Facilitated intervention group postintervention: median 68 (IQR 60?78) years, 65% men

Passive intervention preintervention: median 73 (IQR 62?79) years, 54% men

Passive intervention postintervention: median 72 (IQR 64?79) years, 55% men

Ethnicity: not described

Setting: inpatient rehabilitation

Country: Canada ";68,075;;;;540;https://doi.org/10.1002/14651858.CD009685.pub2;Image guided surgery for the resection of brain tumours;;;;;;;
180;https://doi.org/10.1002/14651858.CD012575.pub2;Implementation interventions to promote the uptake of evidence?based practices in stroke rehabilitation;2020;9;Strasser ;2008;"Experimental group: n = 350, 98.3% men, mean age 65.9 (SD 11.4) years

Control group: n = 439, 96.8% men, mean age 66.6 (SD 12.0) years

Postintervention

Experimental group: n = 233, 96.6% men, mean age 67.6 (SD 11.1) years

Control group: n = 346, 97.4% men, mean age 66.9 (SD 11.9) years";both;"Healthcare professionals: 31 rehabilitation teams, comprising 464 staff of 6 disciplines; medicine, nursing, occupational therapy, speech?language pathology, physiotherapy and social work/case management. Demographics of staff within all clusters not provided.

Patients: stroke survivors (n = 1368) < 90 days' poststroke

Preintervention

Experimental group: n = 350, 98.3% men, mean age 65.9 (SD 11.4) years

Control group: n = 439, 96.8% men, mean age 66.6 (SD 12.0) years

Postintervention

Experimental group: n = 233, 96.6% men, mean age 67.6 (SD 11.1) years

Control group: n = 346, 97.4% men, mean age 66.9 (SD 11.9) years

Ethnicity:

Preintervention

Experimental group: white 57.7%, black 30.9%, Hispanic 8.9%, Asian 0.6%, Native American 0.6%, other/unknown 1.5%

Control group: white 55.6%; black 24.6%; Hispanic 17.1%; Asian 1.1%; Native American 1.1%, other/unknown 0.4%

Postintervention

Experimental group: white 62.7%; black 22.7%; Hispanic 9.4%; Asian 0.9%; Native American 0.9%; other/unknown 3.4%

Control group: white 53.8%; black 24.6%; Hispanic 19.9%; Asian 0.6%; Native American 0.3%; other/unknown 0.9%

Setting: inpatient (acute or subacute)

Country: USA ";;66,289;;;4;https://doi.org/10.1002/14651858.CD008179.pub2;Non?pharmacological interventions for caregivers of stroke survivors;;;;;;;
180;https://doi.org/10.1002/14651858.CD012575.pub2;Implementation interventions to promote the uptake of evidence?based practices in stroke rehabilitation;2020;9;Thomas ;2015;"Intervention A: n = 164, 52% men, median age 77 (IQR 68?83) years

Intervention B: n = 125, 42% men, median age 81 (IQR 74?85) years

Control: n = 124, 41% men, median age 80 (IQR 72?86) years";both;"Healthcare professionals: 12 stroke services comprising nurses (ranging in grade from healthcare assistants to ward managers), occupational therapists and physiotherapists. Demographics of staff within clusters not provided.

Patients: stroke survivors (n = 413)

Intervention A: n = 164, 52% men, median age 77 (IQR 68?83) years

Intervention B: n = 125, 42% men, median age 81 (IQR 74?85) years

Control: n = 124, 41% men, median age 80 (IQR 72?86) years

Ethnicity:

Intervention A: white 96%

Intervention B: white 95%

Control: white 99%

Setting: inpatient stroke units (acute and rehabilitation)

Country: UK ";79,334;79,111;;;72;https://doi.org/10.1002/14651858.CD001244;no relevant data reported;;;;;;;
90;https://doi.org/10.1002/14651858.CD013690.pub2;Type of anaesthesia for acute ischaemic stroke endovascular treatment;2022;7;AnStrokeÿ;2017;Gender (men/women): 49/51;both;"106 men and women randomised: experimental (GA) = 54 and comparator (CSA) = 52; procedure interrupted in GA = 8 and CSA = 7; 1 consent withdrawn in GA arm and 0 lost to follow?up, 90 analysed

Mean age: 72 years (range: 65?80 years)

Gender (men/women): 49/51

Mean NIHSS score: 18 (score range: 15?22)

Mean ASPECTS: 10 (score range: 8?10)

7 (15.6%) participants were converted from CSA to GA

66 (73.3%) participants received IV r?tPA before EVT 

Diagnostic criteria: AIS with LVO in anterior cerebral circulation 

Inclusion criteria

    Aged ? 18 years

    Confirmed occlusion in anterior cerebral circulation by CTA and NIHSS score ? 10 (if right?sided occlusion) or ? 14 (if left?sided occlusion)

    Treatment initiated within 8 hours after onset of symptoms 

Exclusion criteria

    Not eligible for randomisation because of anaesthesiological concerns (airway, agitation, etc.) at the discretion of the attending anaesthetist

    Occlusion of posterior cerebral circulation intracerebral haemorrhage

    Neurological recovery or recanalisation before or during angiography

    Premorbidity mRS score ? 4 or other comorbidities contraindicating embolectomy";72;;65-80;;177;https://doi.org/10.1002/14651858.CD001820.pub3;Dipyridamole for preventing stroke and other vascular events in patients with vascular disease;;;;;;;
90;https://doi.org/10.1002/14651858.CD013690.pub2;Type of anaesthesia for acute ischaemic stroke endovascular treatment;2022;7;CANVAS ;2020;Gender (men/women): 26/14;both;"43 men and women randomised: experimental GA = 21, comparator CSA = 22; procedure interrupted in GA = 8 and CSA = 7; 1 GA and 2 CSA withdrawn due to large infarct and 0 lost to follow?up was reported, 40 analysed

Median age: 65 years (IQR 45?74 years)

Gender (men/women): 26/14

Median NIHSS score 13.9 (score range: 10.2?16.0)

4 (18.2%) participants were converted from CSA to GA after randomisation because of significant agitation

IV r?tPA before EVT was not reported

Diagnostic criteria: AIS with LVO in anterior cerebral circulation

Inclusion criteria

    Aged ? 18 years

    Confirmed occlusion in anterior cerebral circulation by CTA or DSA

    Treatment initiated ? 6 hours after onset of symptoms who were previously functionally independent mRS 0?2

Exclusion criteria

    GSC < 8

    Requiring tracheal intubation for airway protection and lung ventilation occlusion of posterior cerebral circulation (reported only in protocol) intracerebral haemorrhage

    Severely intubation and seizures NIHSS score < 8 or > 35

    Known allergy to specific anaesthetics (propofol), or analgesics (sufentanil and remifentanil)";65;;45-74;;513;https://doi.org/10.1002/14651858.CD009874.pub2;Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases;;;;;;;
90;https://doi.org/10.1002/14651858.CD013690.pub2;Type of anaesthesia for acute ischaemic stroke endovascular treatment;2022;7;GOLIATHÿ;2018;Gender (men/women): 66/62;both;"128 men and women randomised: experimental GA group = 65, comparator CSA group (LA + CSA) = 63; lost to follow?up (not reported); 128 analysed

Mean age: 71.4 (SD 11.4) years

Gender (men/women): 66/62

Mean NIHSS score: 18 (IQR 14?21)

4/63 participants allocated to CSA (6.3%) who crossed over from the CSA to the GA arm but remained in the CSA group for ITT analysis IV r?tPA before EVT: GA = 50 and CSA = 46

96 (75%) participants received IV r?tPA before EVT 

Diagnostic criteria: AIS with large vessels occlusions in the anterior circulation

Inclusion criteria

    Aged ? 18 years

    Groin puncture performed within 6 hours from symptom onset or when last seen well NIHSS > 10 (reported only in protocol)

    mRS ? 2 (reported only in protocol)

    Occlusion of internal carotid artery, internal carotid artery terminus, M1, M2 (reported only in protocol) 

Exclusion criteria

    Intubated at presentation or with a GCS score < 9, mRS score > 2

    Because primary trial endpoint was infarct growth, study required a DWI?MRI scan to establish a baseline (pre?EVT) infarct volume

    Contraindication to MRI infarct > 70 mL

    Posterior circulation stroke (reported only in protocol)

    Allergy to anaesthetics (reported only in protocol)";71,4;;;;284;https://doi.org/10.1002/14651858.CD013498.pub2;(Ultra?)long?acting insulin analogues for people with type 1 diabetes mellitus;;;;;;;
90;https://doi.org/10.1002/14651858.CD013690.pub2;Type of anaesthesia for acute ischaemic stroke endovascular treatment;2022;7;Hu ;2020;Gender (men/women): 72/67;both;"139 men and women randomised: experimental (GA) = 72, comparator (monitored care anaesthesia (MAC)) = 67; 0 lost to follow?up

Mean age: 72 years

Gender (men/women): 72/67

Mean NIHSS and mean ASPECTS not reported

2 (2.9%) participants converted from MAC to GA

Participants received IV r?tPA before EVT (not reported)

Diagnostic criteria: AIS with LVO in posterior cerebral circulation (vertebrobasilar system)

Inclusion criteria

    Aged ? 18 years

    Treated with EVT within 6 hours after symptoms onset

    NIHSS ? 4 at admission and premorbid mRS scores < 2

    Diagnosed with acute posterior circulation stroke caused by vertebrobasilar occlusion verified by CTA, MRA, DSA 

Exclusion criteria

    Increased risk of bleeding, including platelet count < 100 ž 109/L, and history of surgery and substantive organ biopsy within 1 month

    Life expectancy < 90 days

    Contraindications for EVT, including arteriovenous malformation or concomitant aneurysm

    Incomplete information or the follow?up was lost

    Intubated at presentation or with a premorbid mRS score > 2 (score range: 0?6, with a lower score indicating independent living) as well as those who had a GCS score < 9 (score range: 3?15, with a lower score indicating lower levels of consciousness) ";72;;;;286;https://doi.org/10.1002/14651858.CD009068.pub3;Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X?linked dilated cardiomyopathy;;;;;;;
90;https://doi.org/10.1002/14651858.CD013690.pub2;Type of anaesthesia for acute ischaemic stroke endovascular treatment;2022;7;Maurice ;2022;Gender (men/women): 188/157;both;"351 men and woman aged ? 18 years randomised: experimental (GA) = 174, comparator (CSA) = 177

Received allocated intervention:

    GA = 171: 3 did not receive allocated intervention and received CSA (2 contraindication to GA and 1 impossible intubation);

    CSA = 176: 8 did not receive allocated intervention and received GA (7 switched to GA due to: excessive agitation = 3, catheter failure = 2, acute hypoxia = 1, neurological status and respiratory arrest = 1), and 1 directly received GA due to contraindication to CSA;

    consent withdrawal: GA = 5 and CSA = 1; lost to follow?up: GA = 3 and CSA = 1

345 participants were analysed: GA = 169 and CSA = 176

Mean age: 72 years (range: 60?85 years)

Gender (men/women): 188/157

Mean NIHSS score: 16 (score range: 10?22)

Localisation of stroke in left hemisphere: GA = 84 (50%) and CSA = 90 (51%)

8 (4%) participants converted from CSA to GA

Received IV r?tPA before EVT: GA = 111 (66%) and CSA = 114 (65%) 

Diagnostic criteria: AIS with LVO in anterior cerebral circulation

Inclusion criteria

    Aged ? 18 years admitted to the participating centre

    Occlusion of a large vessel in the anterior cerebral circulation

    Undergoing EVT for stroke

    Benefiting from the health insurance system

    Signed informed consent from the participant or legal next of kin

Exclusion criteria

    Pregnant or breastfeeding women

    Already intubated and mechanical ventilated before inclusion in the study

    Intracerebral haemorrhage associated with the ischaemic stroke

    Contraindications to CSA: GCS < 8, agitation not allowing the participant to stay still during procedure, and deglutition disorders

    Contraindications to succinylcholine, hyperkalaemia, and allergy

    BMI > 35 kg/mý

    Allergy to 1 of the anaesthetic drugs

    Uncontrolled hypotension

    Life?threatening comorbidity

    Adults legally protected (under judicial protection, guardianship, or supervision) and people deprived of their liberty

    Unable to walk prior to stroke";72;;60-85;;165;https://doi.org/10.1002/14651858.CD010637.pub2;Physical exercise for the treatment of non?ulcerated chronic venous insufficiency;;;;;;;
90;https://doi.org/10.1002/14651858.CD013690.pub2;Type of anaesthesia for acute ischaemic stroke endovascular treatment;2022;7;Ren ;2020;Gender (men/women): 50/40;both;"90 men and women randomised: experimental GA = 48, comparator CSA = 42; procedure interrupted in GA = 8 and CSA = 7; 0 lost to follow?up, 90 analysed

Mean age: CSA = 69.19 (SD 6.46) years and GA = 69.21 (SD 5.78) years

Gender (men/women): 50/40

Mean NIHSS score: 14 (score range: 11?16)

Mean ASPECTS: 9 (score range: 8?10)

ASA I/II/III: CSA = 5/15/22 and GA = 4/19/25

Mean BMI (kg/mý): CSA = 24.91 (SD 2.59) and GA = 23.84 (SD 2.02)

4 (9.52%) participants converted from CSA to GA

71 (78.8%) participants received IV r?tPA before EVT

Diagnostic criteria: AIS with LVO in anterior cerebral circulation

Inclusion criteria

    ASA grades I?III (reported in trial, but at the protocol was reported as ASA grades II?III)

    Glasgow Outcome Score ? 13 (reported only in protocol)

    NIHSS score < 20 (reported only in trial)

    AIS ? 6.5 hours of symptom onset (reported only in trial)

    Aged ? 60 years (reported in trial, but at protocol was reported as 45?60 years)

    Intracranial proximal arterial occlusion in the anterior cerebral circulation (carotid artery, M1 or M2 segments of the middle cerebral artery) demonstrated by CTA, MRA, or DSA (reported only in trial)

Exclusion criteria

    People with prestroke mRS score > 2

    Haemorrhage demonstrated by CT

    Obvious or known difficult airway; cognitive impairment; disturbance of consciousness; hypoxaemia (SpO2 < 90%) occlusion in the posterior circulation

    History of craniotomy (reported only in protocol)

    Heart disease (heart rate 50 beats/minute) (reported only in protocol)

    Severe hypertension (SBP ? 180 mmHg or DBP ? 110 mmHg) (reported only in protocol)

    BMI > 30 kg/mý (reported in protocol as bodyweight beyond ñ 15% of the standard bodyweight)

    History of liver or kidney dysfunction (reported only in protocol)

    Hypersensitivity (allergic) or intolerance to dexmedetomidine or remifentanil (reported only in protocol)

    Study termination by the researchers from a medical perspective (reported only in protocol)

    Refusal to participate (reported only in protocol)";69,2;69,201;;;;;;;;;;;;
90;https://doi.org/10.1002/14651858.CD013690.pub2;Type of anaesthesia for acute ischaemic stroke endovascular treatment;2022;7;SIESTAÿ;2016;Gender (men/women): 90/60;both;"152 men and women randomised: experimental GA = 73, comparator CSA = 77; 2 excluded (missing informed consent); 150 analysed

Mean age: 71.5 years

Gender (men/women): 90/60

Mean NIHSS score: 17

Mean ASPECTS: 8

1 lost to 24?hour follow?up in CSA arm

IV r?tPA before EVT: GA = 46 (63%) and CSA = 50 (65%)

1 participant who was randomised to GA was mistakenly treated under CSA representing the only major protocol violation

11 (9.2%) participants were intubated at time of evaluation of NIHSS due to:

    midline shift, additional cerebral haemorrhage, or both (n = 7)

    pneumonia (n = 3)

    severe fluctuations of blood pressure including the necessity of high?dose vasopressors (n = 1)

    1 of these participants converted from CSA to GA during intervention because of respiratory insufficiency, and 10 were primarily randomised to the GA group

Diagnostic: AIS with LVO in anterior cerebral circulation

Inclusion criteria

    Aged ? 18 years

    Men or women (reported only in protocol)

    Severe ischaemic stroke defined by an NIHSS score > 10 (range 0?42 with higher scores indicating more severe neurological deficits (a difference of 4 points considered clinically relevant)) (not reported in protocol)

    Isolated or combined occlusion at any level of internal carotid artery or middle cerebral artery

    Decision for thrombectomy according to internal protocol for acute recanalising stroke treatment of the Heidelberg University Hospital and at discretion of physician in charge

Exclusion criteria

    Diagnostic imaging results not clearly depicting site of vessel occlusion

    Clinical or imaging findings suggested occlusion of a cerebral vessel that was not an internal carotid artery or a middle cerebral artery

    Imaging showed intracerebral haemorrhage

    coma at admission (GCS score < 8 (range 3?15 points with 3 being the worst and 15 the best, composed of 3 parameters: best eye response, best verbal response, and best motor response))

    Severe agitation at admission (making groin and vascular access impossible)

    Loss of airway?protective reflexes of at least absence of gag reflex, insufficient saliva handling, observed aspiration, vomiting, or a combination at admission

    Obvious or known difficult airway

    Known intolerance of certain medications for sedation, analgesia, or both (not reported in protocol)";71,5;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;Gruppe 1;Gruppe 2;Gruppe 3;Gruppe 4;Gruppe 5;Gruppe 6;Gruppe 7;Gruppe 8
;;;;;;;;;;;;;;;Anzahl;48;42;;;;;;
;;;;;;;;;;;;;;;Mittelwert;69,21;69,19;;;;;;
;;;;;;;;;;;;;;;;;;;;;;;
;;;;;;;;;;;;;;;;3322,08;2905,98;0;0;0;0;0;0
;;;;;;;;;;;;;;;69,20066667;;;;;;;;
